Mathematical models of skin permeability: Microscopic transport models and their predictions

Computational Biophysics of the Skin

Volumn , Issue , 2014, Pages 187-216

  Kasting, Gerald B ^a   Nitsche, Johannes M ^b  

^a UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER   (United States)

^b State University of New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SKIN PERMEABILITY; TRANSPORT MODELS;

EID: 84974666298     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4032/9789814463850     Document Type: Chapter

References (108)

1. Scheuplein RJ and Blank IH (1971). Permeability of the skin, Physiol Rev, 51, 702-747.
2. Scheuplein RJ (1978). Skin permeation, in The Physiology and Pathophysiology of the Skin (Jarrett A, ed), Academic Press, New York, pp. 1669-1752.
3. Yotsuyanagi T and Higuchi WI (1972). A two phase series model for the transport of steroids across the fully hydrated stratum corneum, J Pharm Pharmacol, 24, 934-941.
4. Michaels AS, Chandrasekaran SK, and Shaw JE (1975). Drug permeation through human skin: theory and in vitro experimental measurement, AIChE J, 21, 985-996.
5. Mitragotri S, Anissimov YG, Bunge AL, Frasch HF, Guy RH, Hadgraft J, Kasting GB, Lane ME, and Roberts MS (2011). Mathematical models of skin permeability: an overview, Int J Pharm, 418, 115-129.
6. Brenner H and Edwards DA (1993). Macrotransport Processes, Butterworth-Heinemann, Boston.
7. Scheuplein RJ (1967). Mechanism of percutaneous absorption II. Transient diffusion and the relative importance of various routes of skin penetration, J Invest Dermatol, 48, 79-88.
8. Ho CK (2004). Probabilistic modeling of percutaneous absorption for risk-based exposure assessments and transdermal drug delivery, Stat Methodol, 1, 47-69.
9. Tang H, Mitragotri S, Blankschtein D, and Langer R (2001). Theoretical description of transdermal transport of hydrophilic permeants:application to low-frequency sonophoresis, J Pharm Sci, 90, 545-568.
10. Tang H, Blankschtein D, and Langer R (2002). Prediction of steadystate skin permeabilities of polar and nonpolar permeants across excised pig skin based on measurements of transient diffusion:characterization of hydration effects on the skin porous pathway, J Pharm Sci, 91, 1891-1907.
11. Kushner J IV, Blankschtein D, and Langer R (2008). Evaluation of hydrophilic permeant transport parameters in the localized and non-localized transport regions of skin treated simultaneously with low-frequency ultrasound and sodium lauryl sulfate, J Pharm Sci, 97, 906-918.
12. Kushner J IV, Blankschtein D, and Langer R (2007). Evaluation of the porosity, the tortuosity, and the hindrance factor for the transdermal delivery of hydrophilic permeants in the context of the aqueous pore pathway hypothesis using dual-radiolabeled permeability experiments, J Pharm Sci, 96, 3263-3282.
13. Dancik Y (2006). Mathematical Models of Diffusion through and Near Skin Appendages: Hair Follicle and Eccrine Sweat Gland Pathways, Ph.D. thesis, Department of Chemical and Biological Engineering, State University of New York, Buffalo.
14. Elias PM (1983). Epidermal lipids, barrier function, and desquamation, J Invest Dermatol, 80, 44s-49s.
15. Grayson S and Elias PM (1982). Isolation and lipid biochemical characterization of stratum corneum membrane complexes:implications for the cutaneous permeability barrier, J Invest Dermatol, 78, 128-135.
16. Elias PM, Goerke J, and Friend DS (1977). Mammalian epidermal barrier layer lipids: composition and influence on structure, J Invest Dermatol, 69, 535-546.
17. Bodde HE, van den Brink I, Koerten HK, and de Haan FHN (1991). Visualization of in vitro percutaneous penetration of mercuric chloride transport through intercellular space versus cellular uptake through desmosomes, J Control Rel, 15, 227-236.
18. Warner RR, Stone KJ, and Boissy YL (2003). Hydration disrupts human stratum corneum ultrastructure, J Invest Dermatol, 120, 275-284.
19. Bouwstra JA, de Graaff A, Gooris GS, Nijsse J, Wiechers JW, and van Aelst AC (2003). Water distribution and related morphology in human stratum corneum at different hydration levels, J Invest Dermatol, 120, 750-758.
20. Kasting GB, Barai ND, Wang T-F, and Nitsche JM (2003). Mobility of water in human stratum corneum, J Pharm Sci, 92, 2326-2340.
21. Kasting GB and Barai ND (2003). Equilibrium water sorption in human stratum corneum, J Pharm Sci, 92, 1624-1631.
22. Robinson M, Visscher M, Laruffa A, and Wickett R (2010). Natural moisturizing factors (NMF) in the stratum corneum (SC). II. Regeneration of NMF over time after soaking, J Cosmet Sci, 61, 23-29.
23. Kushner J IV, Kim D, So PTC, Blankschtein D, and Langer RS (2007). Dual-channel two-photon microscopy study of transdermal transport in skin treated with low-frequency ultrasound and a chemical enhancer, J Invest Dermatol, 127, 2832-2846.
24. Talreja PS, Kasting GB, Kleene NK, Pickens W, and Wang T-F (2001). Visualization of lipid barrier and measurement of lipid path length in human stratum corneum, AAPS Pharm Sci, 3, Article 13.
25. Wang T-F, Kasting GB, and Nitsche JM (2006). A multiphase microscopic diffusion model for stratum corneum permeability. I. Formulation, solution and illustrative results for representative compounds, J Pharm Sci, 95, 620-648.
26. Wang T-F, Kasting GB, and Nitsche JM (2007). A multiphase microscopic diffusion model for stratum corneum permeability. II. Estimation of physicochemical parameters, and application to a large permeability database, J Pharm Sci, 96, 3024-3051.
27. Nitsche JM, Wang T-F, and Kasting GB (2006). A two-phase analysis of solute partitioning into the stratum corneum, J Pharm Sci, 95, 649-666.
28. Anderson BD, Higuchi WI, and Raykar PV (1988). Heterogeneity effects on permeability-partition coefficient relationships in human stratum corneum, Pharm Res, 5, 566-573.
29. Anderson BD and Raykar PV (1989). Solute structure-permeability relationships in human stratum corneum, J Invest Dermatol, 93, 280-286.
30. Raykar PV, Fung M-C, and Anderson BD (1988). The role of protein and lipid domains in the uptake of solutes by human stratum corneum, Pharm Res, 5, 140-150.
31. Hansen S, Naegel A, Heisig M, Wittum G, Neumann D, Kostka K-H, Meiers P, Lehr C-M, and Schaefer UF (2009). The role of corneocytes in skin transport revised-a combined computational and experimental approach, Pharm Res, 26, 1379-1397.
32. Hansen S, Selzer D, Schaefer UF, and Kasting GB (2011). An extended database of keratin binding, J Pharm Sci, 100, 1712-1726.
33. Anissimov YG and Roberts MS (2009). Diffusion modelling of percutaneous absorption kinetics: 4. Effects of a slow equilibration process within stratum corneum on absorption and desorption kinetics, J Pharm Sci, 98, 772-781.
34. Seif S and Hansen S (2012). Measuring the stratum corneum reservoir:desorption kinetics from keratin, J Pharm Sci, 101, 3718-3728.
35. Frasch HF, Barbero AM, Hettick, JM, and Nitsche JM (2011). Tissue binding affects the kinetics of theophylline diffusion through the stratum corneum barrier layer of skin, J Pharm Sci, 100, 2989-2995.
36. Nitsche JM and Frasch HF (2011). Dynamics of diffusion with reversible binding in microscopically heterogeneous membranes:general theory and applications to dermal penetration, Chem Eng Sci, 66, 2019-2041.
37. Kasting GB, Miller MM, and Talreja PS (2005). Evaluation of stratum corneum heterogeneity, in Percutaneous Absorption (Bronaugh RL and Maibach HI, eds), Taylor & Francis, New York, pp. 193-212.
38. Kasting GB, Smith RL, and Anderson BD (1992). Prodrugs for dermal delivery: solubility, molecular size, and functional group effects, in Prodrugs: Topical and Ocular Drug Delivery (Sloan KB, ed), Marcel Dekker, New York, pp. 117-161.
39. Bunge AL and Cleek RL (1995). A new method for estimating dermal absorption from chemical-exposure. 2. Effect of molecular weight and octanol-water partitioning, Pharm Res, 12, 88-95.
40. Cleek RL and Bunge AL (1993). A new method for estimating dermal absorption from chemical exposure. 1. General approach, Pharm Res, 10, 497-506.
41. Kruse J, Golden D, Wilkinson S, Williams F, Kezic S, and Corish J (2007). Analysis, interpretation, and extrapolation of dermal permeation data using diffusion-based mathematical models, J Pharm Sci, 96, 682-703.
42. Dancik Y, Miller MA, Jaworska J, and Kasting GB (2012). Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure, Adv Drug Deliv Revs, 65, 221-236.
43. Kasting GB, Miller MA, and Bhatt V (2008). A spreadsheet-based method for estimating the skin disposition of volatile compounds:application to N,N-diethyl-m-toluamide (DEET), J Occup Environ Hyg, 10, 633-644.
44. Basketter DA, Pease C, Kasting GB, Kimber I, Casati S, Cronin MTD, Diembeck W, Gerberick GF, Hadgraft J, Hartung T, Marty J-P, Nikolaidis E, Patlewicz GY, Roberts D, Roggen E, Rovida C, and van de Sandt H (2007). Skin sensitisation and epidermal disposition. The relevance of epidermal bioavailability for sensitisation hazard identification/ risk assessment, ATLA, 35, 137-154.
45. Raphael AP, Meliga SC, Chen X, Fernando GJP, Flaim C, and Kendall MAF (2013). Depth-resolved characterization of diffusion properties within and across minimally-perturbed skin layers, J Control Rel, 166, 87-94.
46. Andrews SN, Jeong E, and Prausnitz MR (2012). Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum, Pharm Res, 30, 1099-1109.
47. Nitsche JM and Kasting GB (2013). A microscopic multiphase diffusion model of viable epidermis permeability, Biophys J, 104, 2307-2320.
48. Nitsche JM and Kasting GB (2013). A correlation for 1,9-decadiene/ water partition coefficients, J Pharm Sci, 102, 136-144.
49. Nitsche JM and Kasting GB (2013). Permeability of fluid-phase phospholipid bilayers: assessment and useful correlations for permeability screening and other applications, J Pharm Sci, 102, 2005-2032.
50. Johnson ME, Berk DA, Blankschtein D, Golan DE, Jain RK, and Langer RS (1996). Lateral diffusion of small compounds in human stratum corneum and model lipid bilayer systems, Biophys J, 71, 2656-2668.
51. Wasterby P, Oradd G, and Lindblom G (2002). Anisotropic water diffusion in macroscopically oriented lipid bilayers studied by pulsed magnetic field gradient NMR, J Magnet Resonance, 157, 156-159.
52. Safranyos RGA, Caveney S, Miller JG, and Peterson NO (1987). Relative roles of gap junction channels and cytoplasm in cell-to-cell diffusion of fluorescent tracers, Proc Nat Acad Sci USA, 84, 2272-2276.
53. Weber PA, Chang H-C, Spaeth KE, Nitsche JM, and Nicholson BJ (2004). The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities, Biophys J, 87, 958-973.
54. Nitsche JM, Chang H-C, Weber PA, and Nicholson BJ (2004). A transient diffusion model yields unitary gap junctional permeabilities from images of cell-to-cell fluorescent dye transfer between Xenopus oocytes, Biophys J, 86, 2058-2077.
55. Brandner JM, Kief S, Wladykowski E, Houdek P, and Moll I (2006). Tight junction proteins in the skin, Skin Pharmacol Physiol, 19, 71-77.
56. Kretsos K and Kasting GB (2005). Dermal capillary clearance:physiology and modeling, Skin Pharmacol Physiol, 18, 55-74.
57. Singh P and Roberts, MS (1993). Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures, J. Pharm. Sci., 82, 127-131.
58. Singh P and Roberts MS (1993). Dermal and underlying tissue pharmacokinetics of salicylic acid after topical administration, J Pharm Biopharm, 21, 337-373.
59. Singh P and Roberts MS (1996). Local deep tissue penetration of compounds after dermal application: structure-tissue penetration relationships, J Pharmacol Exp Therapeut, 279, 908-917.
60. Kretsos K, Kasting GB, and Nitsche JM (2004). Distributed diffusionclearance model for transient drug distribution within the skin, J Pharm Sci, 93, 2820-2835.
61. Kretsos K, Miller MA, Zamora-Estrada G, and Kasting GB (2008). Partitioning, diffusivity and clearance of skin permeants in mammalian dermis, Int J Pharm, 346, 64-79.
62. Ibrahim R and Kasting GB (2010). Improved method for determining partition and diffusion coefficients in human dermis, J Pharm Sci, 99, 4928-4939.
63. Ibrahim R and Kasting GB (2012). Partitioning and diffusion of parathion in human dermis, Int J Pharm, 435, 33-37.
64. Ibrahim R, Nitsche JM, and Kasting GB (2012). Dermal clearance model for epidermal bioavailability calculations, J Pharm Sci, 101, 2094-2108.
65. Clague DS and Phillips RJ (1996). Hindered diffusion of spherical macromolecules through dilute fibrous media, Phys Fluids, 8, 1720-1731.
66. Phillips RJ (2000). A hydrodynamic model for hindered diffusion of proteins and micelles in hydrogels, Biophys J, 79, 3350-3353.
67. Phillips RJ, Dean WM, and Brady JF (1989). Hindered transport of spherical macromolecules in fibrous membranes and gels, AIChE J, 35, 1761-1769.
68. Phillips RJ, Dean WM, and Brady JF (1990). Hindered transport in fibrous membranes and gels: effect of solute size and fiber configuration, J Colloid Interface Sci, 139, 363-373.
69. Johnson EM, Berk DA, Jain RK, and Deen WM (1996). Hindered diffusion in agarose gels: test of effective medium model, Biophys J, 70, 1017-1026.
70. Clague DS and Phillips RJ (1997). A numerical calculation of the hydraulic permeability of three-dimensional disordered fibrous media, Phys Fluids, 9, 1562-1572.
71. Bert JL, Mathieson JM, and Pearce RH (1982). The exclusion of human serum albumin by human dermal collagenous fibres and within human dermis, Biochem J, 201, 395-403.
72. Bert JL, Pearce RH, and Mathieson JM (1986). Concentration of plasma albumin in its accessible space in postmortem human dermis, Microvasc Res, 32, 211-223.
73. Anissimov YG and Roberts MS (2011). Modelling dermal drug distribution after topical application in human, Pharm Res, 28, 2119-2129.
74. Dancik Y, Anissimov YG, Jepps OG, and Roberts MS (2012). Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application, Brit J Clin Pharmacol, 73, 564-578.
75. Taylor GI (1953). Dispersion of soluble matter in solvent flowing slowly through a tube, Proc Royal Soc London A, 219, 186-203.
76. Aris R (1956). On the dispersion of a solute in a fluid flowing through a tube, Proc Royal Soc London A, 235, 67-77.
77. Kretsos K (2003). Transport Phenomena in the Human Skin, Ph.D. thesis, Department of Chemical Engineering. State University of New York, Buffalo.
78. Kretsos K and Kasting GB (2007). A geometrical model of dermal capillary clearance, Math Biosci, 208, 430-453.
79. Cevc G and Vierl U (2007). Spatial distribution of cutaneous microvasculature and local drug clearance after drug application on the skin, J Control Rel, 118, 18-26.
80. Muha I, Naegel A, Stichel S, Grillo A, Heisig M, and Wittum G (2011). Effective diffusivity in membranes with tetrakaidekahedral cells and implications for the permeability of human stratum corneum, J Membr Sci, 368, 18-25.
81. Naegel A, Heisig M, and Wittum G (2009). A comparison of two- and three-dimensional models for the simulation of the permeability of human stratum corneum, Eur J Pharm Biopharm, 72, 332-338.
82. Johnson ME, Blankschtein D, and Langer R (1997). Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism, J Pharm Sci, 86, 1162-1172.
83. Chen LJ, Lian GP, and Han LJ (2008). Use of "bricks and mortar" model to predict transdermal permeation: model development and initial validation, Ind Eng Chem Res, 47, 6465-6472.
84. Chen L, Lian G, and Han L (2010). Modeling transdermal permeation. Part I. Predicting skin permeability of both hydrophobic and hydrophilic solutes, AIChE J, 56, 1136-1146.
85. Chen L, Han L, and Lian G (2013). Recent advances in predicting skin permeability of hydrophilic solutes, Adv Drug Deliv Rev, 65, 295-305.
86. Wang L, Chen L, Lian G, and Han L (2010). Determination of partition and binding properties of solutes to stratum corneum, Int J Pharm, 398, 114-122.
87. Lian G, Chen L, Pudney PDA, Melot M, and Han L (2010). Modeling transdermal permeation. Part 2. Predicting the dermatopharmacokinetics of percutaneous solute, AIChE J, 56, 2551-2560.
88. Bouwstra JA, Gooris GS, van der Spek JA, and Bras W (1991). Structural investigations of human stratum corneum by small angle X-ray scattering, J Invest Dermatol, 97, 1005-1012.
89. Frasch HF and Barbaro AM (2003). Steady-state flux and lag time in the stratum corneum lipid pathway: results from finite element models, J Pharm Sci, 92, 2196-2207.
90. Lieb WR and Stein WD (1971). The molecular basis of simple diffusion within biological membranes, Curr Top Membr Trans, 11, 1-39.
91. Lieb WR and Stein WD (1986). Simple diffusion across the membrane bilayer, in Transport and Diffusion Across Cell Membranes (Stein WD, ed), Academic Press, Inc., Orlando, pp. 69-112.
92. Wilschut A, ten Berge WF, Robinson PJ, and McKone TE (1995). Estimating skin permeation. The validation of five mathematical skin penetration models, Chemosphere, 30, 1275-1296.
93. Mitragotri S (2002). A theoretical analysis of permeation of small hydrophobic solutes across the stratum corneum based on scaled particle theory, J Pharm Sci, 91, 744-752.
94. Heisig M, Lieckfeldt R, Wittum G, Mazurkevich G, and Lee G (1996). Non steady-state descriptions of drug permeation through stratum corneum. I. The biphasic brick and mortar model, Pharm Res, 13, 421-426.
95. Naegel A, Hansen S, Neumann D, Lehr C-M, Schaefer UF, Wittum G, and Heisig M (2007). In-silico model of skin penetration based on experimentally determined input parameters. Part II. Mathematical modelling of in-vitro diffusion experiments. Identification of critical input parameters, Eur J Pharm Biopharm, 68, 368-379.
96. Tomadakis MM and Sotirchos SV (1993). Transport properties of random arrays of freely overlapping cylinders with various orientation distributions, J Chem Phys, 98, 616-626.
97. Mottram JT and Taylor R (1987). Thermal conductivity of fibrephenolic resin composites. Part II: numerical evaluation, Compos Sci Tech, 29, 211-232.
98. Wang T-F (2003). Microscopic Models for the Structure and Permeability of the Stratum Corneum Barrier Layer of Skin, Ph.D. thesis, Department of Chemical Engineering, State University of New York, Buffalo.
99. Peck KD, Ghanem A-H and Higuchi WI (1994). Hindered diffusion of polar molecules through and effective pore radii estimates of intact and ethanol treated human epidermal membranes, Pharm Res, 11, 1306-1314.
100. Peck KD, Ghanem A-H, and Higuchi WI (1995). The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membrane, J Pharm Sci, 84, 975-982.
101. Mitragotri S (2007). Temperature dependence of skin permeability to hydrophilic and hydrophobic solutes, J Pharm Sci, 96, 1832-1839.
102. Rim JE, Pinsky PM, and van Osdol WW (2009). Multiscale Modeling Framework of Transdermal Drug Delivery, Ann Biomed Eng, 37, 1217-1229.
103. Mitragotri S (2003). Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways, J Control Rel, 86, 69-92.
104. Holz M, Heil SR, and Saccob A (2000). Temperature-dependent selfdffusion coefficients of water and six selected molecular liquids for calibration in accurate 1H NMR PFG measurements, Phys Chem Chem Phys, 2, 4740-4742.
105. Kestin J, Mordechal S, and Wakeham WA (1978). Viscosity of liquid water in the range -8 to 150 deg C, J Phys Chem Ref Data, 7, 941-948.
106. Akomeah F, Martin G, and Brown M (2007). Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties, J Pharm Sci, 96, 824-834.
107. Barbero AM and Frasch HF (2006). Transcellular route of diffusion through stratum corneum: results from finite element models, J Pharm Sci, 95, 2186-2194.
108. Scheuplein RJ (1965). Mechanism of percutaneous absorption I. Routes of penetration and the influence of solubility, J Invest Dermatol, 45, 334-346.